The United States is in talks to release $20 billion in frozen Iranian funds as part of a proposed deal to secure Iran’s stockpile of enriched uranium, a key component of a newly drafted three-page peace plan aimed at ending the ongoing conflict.
Under the terms being negotiated, Iran would relinquish its highly enriched uranium, with portions shipped to a third country and others down-blended within Iran under strict international monitoring. In exchange, the US would unfreeze the substantial financial assets, a move that could reshape geopolitical dynamics in the region. The plan also permits Iran to maintain nuclear research reactors for medical isotope production, provided all nuclear facilities remain above ground.
A second round of discussions between US and Iranian officials is slated for Sunday in Pakistan, signaling urgency in reaching an agreement.
US could unfreeze $20 billion in Iranian funds in exchange for Iranian nuclear program concessions on uranium enrichment, per Axios.
— The Dive Feed (@TheDeepDiveFeed) April 17, 2026
The potential deal comes amid heightened scrutiny of Iran’s nuclear ambitions, which have long been a flashpoint in international relations. If successful, the transfer of uranium and the release of funds could mark a rare diplomatic breakthrough, though the logistics of monitoring and enforcement remain complex. The involvement of a third country for uranium storage adds another layer of coordination to an already delicate process.
Financial markets are attuned to the broader implications of the $20 billion infusion into Iran’s economy, which could influence energy markets and regional investment flows. Any easing of tensions might also impact oil prices, given Iran’s role as a major producer.
Negotiations are still in flux, with no guarantees of a finalized accord. The outcome of the upcoming talks in Pakistan on Sunday will be a critical indicator of whether this $20 billion deal can move forward.
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.